Diogo, Gabriela MacielAndrade, Josimara SouzaSales Júnior, Policarpo AdemarMurta, Silvane Maria FonsecaSantos, Viviane Martins Rebello dosTaylor, Jason Guy2020-06-152020-06-152020DIOGO, G. M. et al. Trypanocidal activity of flavanone derivatives. Molecules, v. 25, n. 2, p. 397-413, 2020. Disponível em: <https://www.mdpi.com/1420-3049/25/2/397>. Acesso em: 10 fev. jan. 2020.1420-3049http://www.repositorio.ufop.br/handle/123456789/12347Chagas disease, also known as American trypanosomiasis, is classified as a neglected disease by the World Health Organization. For clinical treatment, only two drugs have been on the market, Benznidazole and Nifurtimox, both of which are recommended for use in the acute phase but present low cure rates in the chronic phase. Furthermore, strong side effects may result in discontinuation of this treatment. Faced with this situation, we report the synthesis and trypanocidal activity of 3-benzoyl-flavanones. Novel 3-benzoyl-flavanone derivatives were prepared in satisfactory yields in the 3-step synthetic procedure. According to recommended guidelines, the whole cell-based screening methodology was utilized that allowed for the simultaneous use of both parasite forms responsible for human infection. The majority of the tested compounds displayed promising anti-Trypanosoma cruzi activity and the most potent flavanone bearing a nitrofuran moiety was more potent than the reference drug, Benznidazole.en-USrestritoChagas diseaseFlavonoidsTrypanosoma cruziChromanonesIn vitroArtigo publicado em periodicohttps://www.mdpi.com/1420-3049/25/2/397https://doi.org/10.3390/molecules25020397